News
NumeriCor is a new Avicenna member!
We are delighted to welcome NumeriCor as a new Avicenna member!
Avicenna Alliance Glossary of Terms for Computer Modeling and Simulation
This Glossary is a first release with a first short list of definitions; more concepts will be defined, and existing definitions may be adjusted in future updates of this document.
The Role of Artificial Intelligence within In Silico Medicine
A range of authors across academia and industry, representing both the Avicenna Alliance and the Virtual Physiological Human Institute, have produced a new white paper on the potential of computer modelling and simulation in healthcare, with a particular focus on the role of Artificial Intelligence.
Toward a regulatory pathway for Using in Silico Trials in CE Marking of Medical Devices
A team of researchers of the In Silico World project, including several key Avicenna Alliance members, led by Prof. Francesco Pappalardo (University of Catania), Avicenna Alliance’ Pharmaceutical Strategy TF Co-Chair, recently published a Position Paper in IEEE Journal of Biomedical and Health Informatics (J-BHI).
Avicenna Alliance response to the ICHE11A Consultation
The Avicenna Alliance strongly supports and welcomes the ICH’s proposed goal of harmonizing methods and strategies for improved paediatric drug development, particularly through minimizing clinical trials with children.
Avicenna Alliance Feedback to the European Health Data Space Call for Feedback
The Avicenna Alliance welcomes the proposal for the EHDS. The Alliance is a multistakeholder group with the mission of accelerating medical innovation and its practical implementation to ensure safe, affordable and cost-effective health care through the large-scale adoption of in silico medicine and computer modelling and simulation (CM&S). The exchange of and secondary access to good quality health data is particularly important to the Alliance because of its potential to support scientific research and innovation, including in CM&S. There is a distinct need to boost data-driven R&D and innovation to address health challenges which are currently limited by a lack of clear and harmonised data access regulation.
